Conclusion: "ApoE gene polymorphisms are closely correlated with the therapeutic effect of lipid-lowering statins in patients with ischemic cerebral infarction. The lipid-lowering effects are more significant in patients with E2 and E3 genotypes, but were poor in those with the E4 genotype. Personalized regimens should be applied."

• 0
• 0
• 0
• 0

Conclusion: After multiple relevant clinical confounding factors were adjusted, patients with dipper and nondipper high-normal blood pressure had higher LVMI. Abnormalities in circadian blood pressure variability may be associated with the left ventricular hypertrophy.

• 0
• 0
• 0
• 0

Conclusion: For acute ischaemic stroke patients after intravenous thrombolysis, the use of low-dose statins was related to NIHSS improvement at 7 days and inversely related to haemorrhage events in the hospital and death events within 2 years, especially for moderate stroke or noncardioembolic stroke patients.

• 0
• 0
• 0
• 0

We identified a significant increase in total cholesterol and LDL-c levels in women who were carriers of the GA and AG genotypes of the polymorphisms rs628031 and rs594709, respectively, significant effect that is also shown in a dominant inheritance model. Interestingly, we identified an important relationship of the AGC-GAT haplotype with the...

• 0
• 0
• 0
• 0

As a significant and highly potent pharmaceutical intervention to reduce LDL-c and diminish long-term cardiovascular risk, statin therapy is essential for patients with increased LDL-c levels and above moderate cardiovascular risk. Thus, statins should remain the backbone for treating such patients, and, in parallel, the preventive strategy...

• 0
• 1
• 0
• 0